MedCap AB/Skr MCAP
07:00
09:05
11:15
13:20
15:25
1D1W1MYTD1Y5YMAX
About MedCap AB
MedCap AB, established in 2001 and headquartered in Stockholm, Sweden, is a private equity firm specializing in the acquisition and development of small to medium-sized companies within the life sciences sector. The firm focuses on three primary business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap's portfolio includes subsidiaries such as Abilia, which operates in assistive technology; Cardiolex, specializing in ECG solutions; and Unimedic, involved in specialty pharmaceuticals. The company primarily targets investments in Northern Europe, aiming to support businesses with international growth potential. MedCap typically acquires majority stakes, providing capital, expertise, and networks to foster long-term development.
Ticker
Skr MCAP
Sector
Primary listing
XSTO
Employees
647
Headquarters
Stockholm, Sweden
Website
MedCap AB Metrics
BasicAdvanced
kr 8.2bn
34.23
kr 16.07
0.49
-
Price and volume
Market cap
kr 8.2bn
Beta
0.49
52-week high
kr 677.00
52-week low
kr 440.00
Average daily volume
13k
Financial strength
Current ratio
1.862
Quick ratio
1.318
Long term debt to equity
23.303
Total debt to equity
28.82
Interest coverage (TTM)
6.50%
Profitability
EBITDA (TTM)
428.9
Gross margin (TTM)
59.38%
Net profit margin (TTM)
10.66%
Operating margin (TTM)
14.05%
Effective tax rate (TTM)
23.10%
Revenue per employee (TTM)
kr 3,490,000
Management effectiveness
Return on assets (TTM)
8.15%
Return on equity (TTM)
16.36%
Valuation
Price to earnings (TTM)
34.234
Price to revenue (TTM)
3.649
Price to book
5.18
Price to tangible book (TTM)
38.38
Price to free cash flow (TTM)
25.684
Free cash flow yield (TTM)
3.89%
Free cash flow per share (TTM)
21.414
Growth
Revenue change (TTM)
18.58%
Earnings per share change (TTM)
20.81%
3-year revenue growth (CAGR)
18.88%
3-year earnings per share growth (CAGR)
17.12%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.